AUPH logo

AUPHAurinia Pharmaceuticals Inc

$15.17
$0.14
(0.91%)
Today
Updated: 12:50 PM EDT
Reported EarningsMay 7
Mkt Cap$1.97B
Vol330,720.00
News
all
press releases
AUPH Stock Sees Biggest Single-Day Drop In More Than 9 Months Despite Q1 Earnings Beat – Here’s What’s Spooking Investors
Stocktwits
News Placeholder
More News
News Placeholder
Aurinia Pharmaceuticals (AUPH) Q1 Earnings and Revenues Top Estimates
Aurinia (AUPH) delivered earnings and revenue surprises of +38.89% and +0.39%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Aurinia Pharmaceuticals Inc. Profit Advances In Q1
(RTTNews) - Aurinia Pharmaceuticals Inc. (AUP.V) revealed earnings for its first quarter that Increased, from last year...
Nasdaq News: Markets
News Placeholder
Guardian Pharmacy Services (GRDN) Q1 Earnings and Revenues Surpass Estimates
Guardian Pharmacy (GRDN) delivered earnings and revenue surprises of +20.83% and +2.10%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Aurinia Pharmaceuticals (AUPH) to Release Quarterly Earnings on Monday
Aurinia Pharmaceuticals (NASDAQ:AUPH) (TSE:AUP) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at...
MarketBeat
News Placeholder
Short Interest in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Decreases By 15.7%
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Get Free Report) (TSE:AUP) was the target of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totaling 9,112,230 shares, a decrease of 15.7% from the March 31st total of 10,809,496 shares...
MarketBeat
News Placeholder
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Receives Consensus Recommendation of "Hold" from Analysts
Shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Get Free Report) (TSE:AUP) have been assigned a consensus rating of "Hold" from the six ratings firms that are covering the company, MarketBeat...
MarketBeat
News Placeholder
Select Medical (SEM) Lags Q1 Earnings Estimates
Select Medical (SEM) delivered earnings and revenue surprises of -15.91% and +1.54%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Aurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 1-Year High - Still a Buy?
Aurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 1-Year High - Time to Buy...
MarketBeat
News Placeholder
Tudor Investment Corp ET AL Buys Shares of 65,964 Aurinia Pharmaceuticals Inc $AUPH
Tudor Investment Corp ET AL bought a new stake in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH - Free Report) (TSE:AUP) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 65,964 shares of the biotechnology company's stock, valued...
MarketBeat
<
1
2
...
>